Delivery Order SPE2DB25D7068-SPE2DB25FTWBK

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for joint pain treatment. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,300.52 delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML syringes. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $24,234.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical supply. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Department of Defense (DoD) and other government agencies. The contract, valued at $1,685.84, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a delivery order award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for $7,518.77. The contract is for the medical product EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, with a completion date of November 15, 2024. The contract is a firm fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML syringes. The $8,961.84 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) that the company holds with DLA Troop Support Medical to supply pharmaceuticals and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,219.79 contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products to be completed by February 12, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the sole...
This federal contract award, valued at $2,195.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has an ultimate completion date of November 4, 2022 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a firm fixed price of $1,770.52 and a completion date of May 21, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $6,980.96 and a period of performance through May 2, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
  • SPE2DB25D7068
    Indefinite Delivery Contract
  • SPE2DB25D7068-SPE2DB25FTWBK
    Delivery Order

This federal contract award is a Delivery Order (DO) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The DO, valued at $3,328.89, is for the procurement of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. This award is not associated with a set-aside program. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/3/25, 3:08 PM